Literature DB >> 7899588

Acute renal failure associated with the administration of parenteral etidronate.

T L O'Sullivan1, A Akbari, P Cadnapaphornchai.   

Abstract

Etidronate-induced toxicity has not been well documented in humans. This is a detailed account of a case of acute renal failure believed to be due to etidronate. The patient inadvertently received an overdose of etidronate by the intravenous route and subsequently developed acute renal failure as evidenced by a rapid and sustained rise in serum creatinine. The temporal relationship was strongly suggestive of etidronate-induced nephrotoxicity. Other possible causes, such as postrenal obstruction, acute tubular necrosis due to hypotension or sepsis, and other nephrotoxic drugs were excluded through diagnostic and laboratory tests.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899588     DOI: 10.3109/08860229409044906

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  3 in total

Review 1.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 2.  Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates.

Authors:  Johann D Ringe; Parvis Farahmand
Journal:  Clin Rheumatol       Date:  2006-11-23       Impact factor: 2.980

Review 3.  Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women.

Authors:  Philip Sambrook
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.